vimarsana.com

Latest Breaking News On - Department of hematology hematopoietic cell transplantation - Page 1 : vimarsana.com

Dr Phillips on the Safety and Efficacy of Glofitamab in Relapsed/Refractory MCL

Tycel Phillips, MD, MPH, discusses updated efficacy and safety data with glofitamab for the treatment of relapsed/refractory mantle cell lymphoma.

City of Hope s Dr Tycel Phillips Discusses Promise of Glofitamab in Heavily Pretreated MCL

Glofitamab is currently being investigated in a phase 1/2, multicenter, open-label, dose-escalation study as monotherapy and in combination with obinutuzumab, following 1-time fixed-dose pretreatment with obinutuzumab.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.